147 related articles for article (PubMed ID: 2597170)
1. Tianeptine, a new tricyclic antidepressant metabolized by beta-oxidation of its heptanoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice.
Fromenty B; Freneaux E; Labbe G; Deschamps D; Larrey D; Letteron P; Pessayre D
Biochem Pharmacol; 1989 Nov; 38(21):3743-51. PubMed ID: 2597170
[TBL] [Abstract][Full Text] [Related]
2. Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
Le Dinh T; Freneaux E; Labbe G; Letteron P; Degott C; Geneve J; Berson A; Larrey D; Pessayre D
J Pharmacol Exp Ther; 1988 Nov; 247(2):745-50. PubMed ID: 3183967
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic.
Fréneaux E; Labbe G; Letteron P; The Le Dinh ; Degott C; Genève J; Larrey D; Pessayre D
Hepatology; 1988; 8(5):1056-62. PubMed ID: 3417225
[TBL] [Abstract][Full Text] [Related]
4. Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome.
Deschamps D; Fisch C; Fromenty B; Berson A; Degott C; Pessayre D
J Pharmacol Exp Ther; 1991 Nov; 259(2):894-904. PubMed ID: 1941634
[TBL] [Abstract][Full Text] [Related]
5. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
Fromenty B; Fisch C; Labbe G; Degott C; Deschamps D; Berson A; Letteron P; Pessayre D
J Pharmacol Exp Ther; 1990 Dec; 255(3):1371-6. PubMed ID: 2124623
[TBL] [Abstract][Full Text] [Related]
6. Decreased mitochondrial oxidation of fatty acids in pregnant mice: possible relevance to development of acute fatty liver of pregnancy.
Grimbert S; Fromenty B; Fisch C; Letteron P; Berson A; Durand-Schneider AM; Feldmann G; Pessayre D
Hepatology; 1993 Apr; 17(4):628-37. PubMed ID: 8477967
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.
Geneve J; Hayat-Bonan B; Labbe G; Degott C; Letteron P; Freneaux E; Dinh TL; Larrey D; Pessayre D
J Pharmacol Exp Ther; 1987 Sep; 242(3):1133-7. PubMed ID: 3116197
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids.
Freneaux E; Fromenty B; Berson A; Labbe G; Degott C; Letteron P; Larrey D; Pessayre D
J Pharmacol Exp Ther; 1990 Nov; 255(2):529-35. PubMed ID: 2123005
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids inhibit mitochondrial matrix acyl-CoA dehydrogenases and fatty acid beta-oxidation.
Lettéron P; Brahimi-Bourouina N; Robin MA; Moreau A; Feldmann G; Pessayre D
Am J Physiol; 1997 May; 272(5 Pt 1):G1141-50. PubMed ID: 9176224
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice.
Lettéron P; Sutton A; Mansouri A; Fromenty B; Pessayre D
Hepatology; 2003 Jul; 38(1):133-40. PubMed ID: 12829995
[TBL] [Abstract][Full Text] [Related]
11. Metabolic activation of the antidepressant tianeptine. II. In vivo covalent binding and toxicological studies at sublethal doses.
Letteron P; Labbe G; Descatoire V; Degott C; Loeper J; Tinel M; Larrey D; Pessayre D
Biochem Pharmacol; 1989 Oct; 38(19):3247-51. PubMed ID: 2818624
[TBL] [Abstract][Full Text] [Related]
12. The metabolic pathways of tianeptine, a new antidepressant, in healthy volunteers.
Grislain L; Gele P; Bertrand M; Luijten W; Bromet N; Salvadori C; Kamoun A
Drug Metab Dispos; 1990; 18(5):804-8. PubMed ID: 1981739
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of human blood lymphocytes as a model to study the effects of drugs on human mitochondria. Effects of low concentrations of amiodarone on fatty acid oxidation, ATP levels and cell survival.
Fromenty B; Letteron P; Fisch C; Berson A; Deschamps D; Pessayre D
Biochem Pharmacol; 1993 Aug; 46(3):421-32. PubMed ID: 8347165
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver.
Larosche I; Lettéron P; Fromenty B; Vadrot N; Abbey-Toby A; Feldmann G; Pessayre D; Mansouri A
J Pharmacol Exp Ther; 2007 May; 321(2):526-35. PubMed ID: 17277197
[TBL] [Abstract][Full Text] [Related]
15. Microvesicular steatosis induced by a short chain fatty acid: effects on mitochondrial function and correlation with gene expression.
Jolly RA; Ciurlionis R; Morfitt D; Helgren M; Patterson R; Ulrich RG; Waring JF
Toxicol Pathol; 2004; 32 Suppl 2():19-25. PubMed ID: 15503661
[TBL] [Abstract][Full Text] [Related]
16. Effect of salicylic acid on mitochondrial-peroxisomal fatty acid catabolism.
Yoshida Y; Fujii M; Brown FR; Singh I
Pediatr Res; 1988 Mar; 23(3):338-41. PubMed ID: 3353181
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by perhexiline of oxidative phosphorylation and the beta-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions.
Deschamps D; DeBeco V; Fisch C; Fromenty B; Guillouzo A; Pessayre D
Hepatology; 1994 Apr; 19(4):948-61. PubMed ID: 8138270
[TBL] [Abstract][Full Text] [Related]
18. Neurochemical profile of tianeptine, a new antidepressant drug.
Kato G; Weitsch AF
Clin Neuropharmacol; 1988; 11 Suppl 2():S43-50. PubMed ID: 3052825
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of mitochondrial fatty acid oxidation in pentenoic acid-induced fatty liver. A possible model for Reye's syndrome.
Thayer WS
Biochem Pharmacol; 1984 Apr; 33(8):1187-94. PubMed ID: 6712730
[TBL] [Abstract][Full Text] [Related]
20. Ammonium chloride inhibits pyruvate oxidation in rat liver mitochondria: a possible cause of fatty liver in Reye's syndrome and urea cycle defects.
Maddaiah VT; Kumbar U
Clin Sci (Lond); 1994 Nov; 87(5):499-503. PubMed ID: 7874836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
